Ramsey, Scott D <br/><br/>
Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma.  [electronic resource] 

 -  British journal of haematology  Dec 2016 
 - 860-867 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.14316  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Autografts<br/>Brentuximab Vedotin<br/>Consolidation Chemotherapy<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Hodgkin Disease--psychology<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Quality of Life<br/>Salvage Therapy--methods<br/>Surveys and Questionnaires